Current concepts in ovarian epithelial tumorigenesis: Correlation between morphological and molecular data

Histology and Histopathology

Volumn 21, Issue 1-3, 2006, Pages 81-92

  Scott, M ^a   McCluggage, W Glenn ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Molecular genetics; Morphological types; Ovary; Pathogenesis

Indexed keywords

CANCER STAGING; CARCINOGENESIS; CELL FATE; CELL LINEAGE; CORRELATION ANALYSIS; CYSTADENOCARCINOMA; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; MOLECULAR GENETICS; MUCINOUS CARCINOMA; OVARY CARCINOMA; OVARY CYST; PATHOGENESIS; REVIEW; SYSTEMATIC REVIEW;

ADENOCARCINOMA; ANTINEOPLASTIC PROTOCOLS; EPITHELIUM; FEMALE; HUMANS; MUTATION; OVARIAN NEOPLASMS; PRECANCEROUS CONDITIONS; PROGNOSIS;

EID: 29844436184     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Adams A.T. and Auersperg N. (1981). Transformation of cultured rat ovarian surface epithelial cells by Kirsten murine sarcoma virus. Cancer Res. 41, 2063-2072.
2. Auersperg N., Siemens C.H. and Myrdal S.E. (1984). Human ovarian surface epithelium in primary culture. In Vitro 20, 743-755.
3. Auersperg N., Maines-Bandiera S.L., Dyck H.G. and Kruk P.A. (1994). Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes. Lab Invest. 71, 510-518.
4. Auersperg N., Maines-Bandiera S., Booth J.H., Lynch H.T., Godwin A. K. and Hamilton T.C. (1995). Expression of two mucin antigens in cultured human ovarian surface epithelium: influence of a family history of ovarian cancer. Am. J. Obstet. Gynecol. 173, 558-565.
5. Auersperg N., Maines-Bandiera S.L. and Dyck H.G. (1997). Ovarian carcinogenesis and the biology of ovarian surface epithelium. J. Cell Physiol. 173, 261-265.
6. Auersperg N., Wong A.S., Choi K.C., Kang S.K. and Leung P.C. (2001). Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev. 22, 255-288.
7. Auersperg N., Ota T. and Mitchell G.W. (2002). Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches. Int. J. Gynecol. Cancer 12, 691-703.
8. Bao R., Abdollahi A. and Hamilton T.C. (2002). The biology of the ovarian surface epithelium. In: Ovarian cancer. 2nd ed. Jacobs I.J. (ed). Oxford University Press. Oxford. pp 113-117.
9. Bast R.C. Jr. (2003). Status of tumor markers in ovarian cancer screening. J. Clin. Oncol. 21 Suppl, 200-205.
10. Bingham C., Roberts D. and Hamilton T.C. (2001). The role of molecular biology in understanding ovarian cancer initiation and progression. Int. J. Gynecol. Cancer 11, 7-11.
11. Blaustein A., Kaganowicz A. and Wells J. (1982). Tumor markers in inclusion cysts of the ovary. Cancer 49, 722-726.
12. Bos J.L. (1989). ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689.
13. Brewer M.A., Johnson K., Follen M., Gershenson D. and Bast R. Jr (2003). Prevention of ovarian cancer: intraepithelial neoplasia. Clin. Cancer Res. 9, 20-30.
14. Burks R.T., Sherman M.E. and Kurman R.J. (1996). Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am. J. Surg. Pathol. 20, 1319-1330.
15. Campbell I.G., Morland S.J., Obata K., Neville P.J. and Thomas N. (2002). Genetic analysis of putative precursors of ovarian cancer. In: Ovarian cancer. 2nd ed. Jacobs I.J. (ed). Oxford University Press. Oxford. pp 91-95.
16. Campbell I.G., Russell S.E., Choong D.Y., Montgomery K.G., Ciavarella M.L., Hooi C.S., Cristiano B.E., Pearson R.B. and Phillips W.A. (2004). Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res. 64, 7678-7681.
17. Catasus L., Bussaglia E., Rodriguez I., Gallardo A., Pons C., Irving J.A. and Prat J. (2004). Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas. Hum. Pathol. 35, 1360-1368.
18. Cuatrecasas M., Villanueva A., Matias-Guiu X. and Prat J. (1997). K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. Cancer 79, 1581-1586.
19. Cvetkovic D. (2003). Early events in ovarian oncogenesis. Reprod. Biol. Endocrinol. 1, 68.
20. Deligdisch L., Einstein A.J., Guera D. and Gil J. (1995). Ovarian dysplasia in epithelial inclusion cysts. A morphometric approach using neural networks. Cancer 76, 1027-1034.
21. Deligdisch L., Gil J., Kerner H., Wu H.S., Beck D. and Gershoni-Baruch R. (1999). Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations. Cancer 86, 1544-1550.
22. Diebold J., Seemuller F. and Lohrs U. (2003). K-RAS mutations in ovarian and extraovarian lesions of serous tumors of borderline malignancy. Lab. Invest. 83, 251-258.
23. Dinulescu D.M., Ince T.A., Quade B.J., Shafer S.A., Crowley D., and Jacks T. (2005). Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat. Med. 11, 63-70.
24. Dubeau L. (1999). The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol. Oncol. 72, 437-442.
25. Eichhorn J.H. and Young R.H. (2004). Transitional cell carcinoma of the ovary: a morphologic study of 100 cases with emphasis on differential diagnosis. Am. J. Surg. Pathol. 28, 453-463.
26. Eichhorn J.H., Bell D.A., Young R.H. and Scully R.E. (1999). Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am. J. Surg. Pathol. 23, 397-409.
27. Evans M.F. and Herrington C.S. (2001). Allelic imbalance is not restricted to numerically abnormal chromosomes in epithelial ovarian tumours. J. Pathol. 195, 443-450.
28. Evans M.F., McDicken I.W. and Herrington C.S. (1999). Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours. J. Pathol. 189, 53-59.
29. Fallows S., Price J., Atkinson R.J., Johnston P.G., Hickey I. and Russell S.E. (2001). P53 mutation does not affect prognosis in ovarian epithelial malignancies. J. Pathol. 194, 68-75.
30. Fathalla M.F. (1971). Incessant ovulation - a factor in ovarian neoplasia? Lancet 2, 163.
31. Fearon E.R. and Vogelstein B. (1990). A genetic model for colorectal tumorigenesis. Cell 61, 759-767.
32. Feeley K.M. and Wells M. (2001). Precursor lesions of ovarian epithelial malignancy. Histopathology 38, 87-95.
33. Fox H. and Singh N. (2002). Pathology of epithelial ovarian cancer. In: Ovarian cancer. 2nd ed. Jacobs I.J. (ed). Oxford University Press. Oxford. pp 57-66.
34. Fukunaga M. and Ushigome S. (1998). Epithelial metaplastic changes in ovarian endometriosis. Mod. Pathol. 11, 784-788.
35. Fukunaga M., Nomura K., Ishikawa E. and Ushigome S. (1997). Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 30, 249-255.
36. Garrett A.P., Lee, K.R., Colitti C.R., Muto M.G., Berkowitz R.S. and Mok S.C. (2001). K-ras mutation may be an early event in mucinous ovarian tumorigenesis. Int. J. Gynecol. Pathol. 20, 244-251.
37. Gemignani M.L., Schlaerth A.C., Bogomolniy F., Barakat R.R., Lin O., Soslow R., Venkatraman E. and Boyd J. (2003). Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma. Gynecol. Oncol. 90, 378-381.
38. Gershenson, D. M., Tortolero-Luna, G., Malpica, A., Baker, V. V., Whittaker, L., Johnson, E., and Follen, M. M. (1996). Ovarian intraepithelial neoplasia and ovarian cancer. Obstet. Gynecol. Clin. North Am. 23, 475-543.
39. Gilks C.B. (2004). Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data. Int. J. Gynecol. Pathol. 23, 200-205.
40. Godwin A.K., Testa J.R. and Hamilton T.C. (1993). The biology of ovarian cancer development. Cancer 71, Suppl 530-536.
41. Haas C.J., Diebold J., Hirschmann A., Rohrbach H. and Lohrs U. (1999). In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential. Virchows Arch. 434, 117-120.
42. Halperin R., Zehavi S., Langer R., Hadas E., Bukovsky I. and Schneider D. (2001). Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer. Int. J. Gynecol. Cancer 11, 403-408.
43. Hart W.R. (2005). Mucinous tumors of the ovary: a review. Int. J. Gynecol. Pathol. 24, 4-25.
44. Hauptmann S., Denkert C., Koch I., Petersen S., Schluns K., Reles A., Dietel M. and Petersen I. (2002). Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. Hum. Pathol. 33, 632-641.
45. Hutson R., Ramsdale J. and Wells M. (1995). p53 protein expression in putative precursor lesions of epithelial ovarian cancer. Histopathology 27, 367-371.
46. Kabawat S.E., Bast R.C. Jr, Bhan A.K., Welch W.R., Knapp R.C., and Colvin R.B. (1983). Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int. J. Gynecol. Pathol. 2, 275-285.
47. Kruk P.A., Uitto V.J., Firth J.D., Dedhar S. and Auersperg N. (1994). Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix. Exp. Cell Res. 215, 97-108.
48. Lakhani S.R., Manek S., Penault-Llorca F., Flanagan A., Arnout L., Merrett S., McGuffo L., Steele D., Devilee P., Klijn J.G., Meijers-Heijboer H., Radice P., Pilotti S., Nevanlinna H., Butzow R., Sobol H., Jacquemier J., Lyonet D.S., Neuhausen S.L., Weber B., Wagner T., Winqvist R., Bignon Y.J., Monti F., Schmitt F., Lenoir G., Seitz S., Hamman U., Pharoah P., Lane G., Ponder B., Bishop D.T. and Easton D.F. (2004). Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin. Cancer Res. 10, 2473-2481.
49. Lauchlan S.C. (1994). The secondary mullerian system revisited. Int. J. Gynecol. Pathol. 13, 73-79.
50. Lax S.F. (2004). Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch. 444, 213-223.
51. Mandai M., Konishi I., Kuroda H., Komatsu T., Yamamoto, S., Nanbu K., Matsushita K., Fukumoto M., Yamabe H. and Mori T. (1998). Heterogeneous distribution of K-ras-mutated epithelia in mucinous ovarian tumors with special reference to histopathology. Hum. Pathol. 29, 34-40.
52. Matias-Guiu X., Catasus L., Bussaglia E., Lagarda H., Garcia A., Pons C., Munoz J., Arguelles R., Machin P. and Prat J. (2001). Molecular pathology of endometrial hyperplasia and carcinoma. Hum. Pathol. 32, 569-577.
53. Mittal K.R., Zeleniuch-Jacquotte A., Cooper J.L. and Demopoulos R.I. (1993). Contralateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions. Int. J. Gynecol. Pathol. 12, 59-63.
54. Nicosia S.V., Bai W., Cheng J.Q., Coppola D. and Kruk P.A. (2003). Oncogenic pathways implicated in ovarian epithelial cancer. Hematol. Oncol. Clin. North Am. 17, 927-943.
55. O'Neill C.J., Deavers D.T., Malpica A., Foster H. and McCluggage W.G. (2005). An immunohistochemical comparison between low grade and high grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, bcl-2, Her-2/neu and c-kit in high grade neoplasms. Am. J. Surg. Pathol. 29, 1034-1041.
56. Obata K., Morland S.J., Watson R.H., Hitchcock A., Chenevix-Trench G., Thomas E.J. and Campbell I.G. (1998). Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res. 58, 2095-2097.
57. Ortiz B.H., Ailawadi M., Colitti C., Muto M.G., Deavers M., Silva E.G., Berkowitz R.S., Mok S.C. and Gershenson D.M. (2001). Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Res. 61, 7264-7267.
58. Peyssonnaux C. and Eychene A. (2001). The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell 93, 53-62.
59. Piek J.M., Dorsman J.C., Shvarts A., Ansink A.C., Massuger L.F., Scholten P., van Diest P.J., Dijkstra J.C., Weegenaar J., Kenemans P. and Verheijen R.H. (2004). Cultures of ovarian surface epithelium from women with and without a hereditary predisposition to develop female adnexal carcinoma. Gynecol. Oncol. 92, 819-826.
60. Plaxe S.C., Deligdisch L., Dottino P.R. and Cohen C.J. (1990). Ovarian intraepithelial neoplasia demonstrated in patients with stage I ovarian carcinoma. Gynecol. Oncol. 38, 367-372.
61. Prat J. and De Nictolis M. (2002). Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am. J. Surg. Pathol. 26, 1111-1128.
62. Puls L.E., Powell D.E., DePriest P.D., Gallion H.H., Hunter J.E., Kryscio R.J. and van N.J. Jr (1992). Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma. Gynecol. Oncol. 47, 53-57.
63. Resta L., Russo S., Colucci G.A. and Prat J. (1993). Morphologic precursors of ovarian epithelial tumors. Obstet. Gynecol. 82, 181-186.
64. Riopel M.A., Ronnett B.M. and Kurman R.J. (1999). Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am. J. Surg. Pathol. 23, 617-635.
65. Rodriguez G.C., Walme D.K., Cline M., Krigman H., Lessey B.A., Whitaker R.S., Dodge R. and Hughes C.L. (1998). Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? J. Soc. Gynecol. Invest. 5, 271-276.
66. Ronnett B.M., Kurman R.J., Zahn, C.M., Shmookler B.M., Jablonski K.A., Kass M.E. and Sugarbaker P.H. (1995). Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum. Pathol. 26, 509-524.
67. Ross J.S., Yang F., Kallakury B.V., Sheehan C.E., Ambros R.A. and Muraca P.J. (1999). HER-2/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary. Am. J. Clin. Pathol. 111, 311-316.
68. Russell S.E. and McCluggage W.G. (2004). A multistep model for ovarian tumorigenesis: the value of mutation analysis in the KRAS and BRAF genes. J. Pathol. 203, 617-619.
69. Sainz D.I.C., Eichhorn J.H., Rice L.W., Fuller A.F. Jr, Nikrui N. and Goff B.A. (1996). Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol. Oncol. 60, 238-244.
70. Salazar H., Godwin A.K., Daly M.B., Laub P.B., Hogan W.M., Rosenblum N., Boente M.P., Lynch H.T. and Hamilton T.C. (1996). Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J. Natl. Cancer Inst. 88, 1810-1820.
71. Schuyer M., Henzen-Logmans S.C., van der Burg M.E., Fieret J.H., Derksen C., Look M.P., Meijer-van Gelder M.E., Klijn J.G., Foekens J.A. and Berns E.M. (1999). Genetic alterations in ovarian borderline tumours and ovarian carcinomas. Eur. J. Obstet. Gynecol. Reprod. Biol. 82, 147-150.
72. Schwartz D.R., Kardia S.L., Shedden K.A., Kuick R., Michailidis G., Taylor J.M., Misek D.E., Wu R., Zhai Y., Darrah D.M., Reed H., Ellenson L.H., Giordano T.J., Fearon E.R., Hanash S.M. and Cho K.R. (2002). Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res. 62, 4722-4729.
73. Scully R.E. (1995). Pathology of ovarian cancer precursors. J. Cell Biochem. Suppl. 23, 208-218.
74. Seidman J.D. (1996). Prognostic importance of hyperplasia and atypia in endometriosis. Int. J. Gynecol. Pathol. 15, 1-9.
75. Seidman J.D. and Kurman R.J. (1996). Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am. J. Surg. Pathol. 20, 1331-1345.
76. Seidman J.D., Kurman R.J. and Ronnett B.M. (2003). Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am. J. Surg. Pathol. 27, 985-993.
77. Seidman J.D., Horkayne-Szakaly I., Haiba M., Boice C.R., Kurman R.J. and Ronnett B.M. (2004). The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int. J. Gynecol. Pathol. 23, 41-44.
78. Shih I. and Kurman R.J. (2004). Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am. J. Pathol. 164, 1511-1518.
79. Singer G., Kurman R.J., Chang H.W., Cho S.K. and Shih I. (2002). Diverse tumorigenic pathways in ovarian serous carcinoma. Am. J. Pathol. 160, 1223-1228.
80. Singer G., Shih I., Truskinovsky A., Umudum H. and Kurman R.J. (2003). Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor). Int. J. Gynecol. Pathol. 22, 37-41.
81. Smith Sehdev A.E., Sehdev P.S. and Kurman R.J. (2003). Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases. Am. J. Surg. Pathol. 27, 725-736.
82. Staebler A., Heselmeyer-Haddad K., Bell K., Riopel M., Perlman E., Ried T. and Kurman R.J. (2002). Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas. Hum. Pathol. 33, 47-59.
83. Stern R.C., Dash R., Bentley R.C., Snyder M.J., Haney A.F. and Robboy S.J. (2001). Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int. J. Gynecol. Pathol. 20, 133-139.
84. Sundfeldt K., Piontkewitz Y., Ivarsson K., Nilsson O., Hellberg P., Brannstrom M., Janson P.O., Enerback S. and Hedin L. (1997). E-cadherin expression in human epithelial ovarian cancer and normal ovary. Int. J. Cancer 74, 275-280.
85. Takeshima Y., Amatya V.J., Daimaru Y., Nakayori F., Nakano T. and Inai K. (2001). Heterogeneous genetic alterations in ovarian mucinous tumors: application and usefulness of laser capture microdissection. Hum. Pathol. 32, 1203-1208.
86. Taus P., Petru E., Gucer F., Pickel H. and Lahousen M. (1997). Primary serous papillary carcinoma of the peritoneum: a report of 18 patients. Eur. J. Gynaecol. Oncol. 18, 171-172.
87. Tavassoli F.A. and Devilee P. (2003). Tumors of the ovary and peritoneum. In: World health organisation classification of tumors. Tumors of the breast and female genital organs. IARC Press. Lyon. pp 117-124.
88. Tresserra F., Grases P.J., Labastida R. and Ubeda A. (1998). Histological features of the contralateral ovary in patients with unilateral ovarian cancer: a case control study. Gynecol. Oncol. 71, 437-441.
89. Wang N. (2002). Cytogenetics and molecular genetics of ovarian cancer. Am. J. Med. Genet. 115, 157-163.
90. Wells M. (2004). Recent advances in endometriosis with emphasis on pathogenesis, molecular pathology, and neoplastic transformation. Int. J. Gynecol. Pathol. 23, 316-320.
91. Wen W.H., Reles A., Runnebaum I.B., Sullivan-Halley J., Bernstein L., Jones L.A., Felix J. C., Kreienberg R., el Naggar A. and Press M.F. (1999). p53 mutations and expression in ovarian cancers: correlation with overall survival. Int. J. Gynecol. Pathol. 18, 29-41.
92. Werness B.A., Afify A.M., Bielat K.L., Eltabbakh G.H., Piver M.S. and Paterson J.M. (1999). Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer. Hum. Pathol. 30, 151-157.